Evidence map›Paper›PMID 31647540›Full record

ReviewBrain : a journal of neurology2020

Freezing of gait: understanding the complexity of an enigmatic phenomenon.

Daniel Weiss, Anna Schoellmann, Michael D Fox, Nicolaas I Bohnen, Stewart A Factor, Alice Nieuwboer, Mark Hallett, Simon J G Lewis

Erratum issuedAbstract readReview
In one paragraph

Review in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Freezing of Gait: A Tribute to Nir Giladi.The European journal of neuroscience · 2026
    Article
  6. The Noradrenergic Brain in Parkinson's Disease.Current neurology and neuroscience reports · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Aberrant Beta-Band Network Alteration Preceding Freezing of Gait in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  11. Article
  12. Review
  13. Observational
  14. An updated definition of freezing of gait.Nature reviews. Neurology · 2026
    Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Daniel WeissCentre for Neurology, Department for Neurodegenerative Diseases, and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Anna SchoellmannCentre for Neurology, Department for Neurodegenerative Diseases, and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Michael D FoxBerenson-Allen Center, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical Center, Boston, MA, USA.
Nicolaas I BohnenDepartments of Radiology and Neurology, University of Michigan, Ann Arbor, MI, USA; Veterans Administration Ann Arbor Healthcare System, Ann Arbor, MI, USA; Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, MI, USA.
Stewart A FactorDepartment of Neurology, Emory School of Medicine, Atlanta, GA, USA.
Alice NieuwboerNeuromotor Rehabilitation Research Group, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Mark HallettNational Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Simon J G LewisParkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Australia.

Funding

Pathophysiology of Basal Ganglia DisordersZIANS003031 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI HALLETT, MARK · 2009 to 2023
$22.7M
Tomography and Data AnalysisP01NS015655 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 1985 to 2012
$13.0M
Public Outreach and Education CoreP50NS091856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2014 to 2019
$10.1M
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptomsR01MH113929 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI MICHAEL D FOX · 2017 to 2026
$6.9M
Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson DiseaseR01NS099535 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNEN, NICOLAAS IDA · 2017 to 2020
$2.1M
Hyposmia, Cholinergic Denervation and Incipient Cognitive Decline in PDR01NS070856 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNEN, NICOLAAS IDA · 2010 to 2014
$1.9M
Emory Clinical Research Site for NEXTU10NS077366 · NINDS · EMORY UNIVERSITY · PI FACTOR, STEWART A · 2011 to 2017
$1.8M
IMAGING BIOMARKERS OF PROGRESSION OF MOBILITY IMPAIRMENT IN PDI01RX000317 · VA · VETERANS HEALTH ADMINISTRATION · PI BOHNEN, NICOLAAS IDA · 2012 to 2014
–
NIMH NIH HHS R01 MH113929NINDS NIH HHS P01 NS015655NINDS NIH HHS P50 NS091856NINDS NIH HHS R01 NS070856NINDS NIH HHS R01 NS099535NINDS NIH HHS U10 NS077366RRD VA I01 RX000317RRD VA I01 RX001631
6 · The paper itself

Abstract

Diverse but complementary methodologies are required to uncover the complex determinants and pathophysiology of freezing of gait. To develop future therapeutic avenues, we need a deeper understanding of the disseminated functional-anatomic network and its temporally associated dynamic processes. In this targeted review, we will summarize the latest advances across multiple methodological domains including clinical phenomenology, neurogenetics, multimodal neuroimaging, neurophysiology, and neuromodulation. We found that (i) locomotor network vulnerability is established by structural damage, e.g. from neurodegeneration possibly as result from genetic variability, or to variable degree from brain lesions. This leads to an enhanced network susceptibility, where (ii) modulators can both increase or decrease the threshold to express freezing of gait. Consequent to a threshold decrease, (iii) neuronal integration failure of a multilevel brain network will occur and affect one or numerous nodes and projections of the multilevel network. Finally, (iv) an ultimate pathway might encounter failure of effective motor output and give rise to freezing of gait as clinical endpoint. In conclusion, we derive key questions from this review that challenge this pathophysiological view. We suggest that future research on these questions should lead to improved pathophysiological insight and enhanced therapeutic strategies.

Indexed as

Apolipoprotein E4BrainBrain MappingCytochrome P-450 CYP2D6Functional NeuroimagingGait Disorders, NeurologicGlucosylceramidaseHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Magnetic Resonance ImagingMutationNeural PathwaysParkinson DiseasePositron-Emission TomographyReceptors, Dopamine D2Tomography, Emission-Computed, Single-PhotonApolipoprotein E4Cytochrome P-450 CYP2D6GlucosylceramidaseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Receptors, Dopamine D2freezing of gait (FoG)geneticsneurophysiologyParkinson’s diseasestimulation

Identifiers

PMID31647540
PMCPMC6938035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.